AdaptHealth Corp
AHCO
ISIN US00653Q1022 / Valor 51036706
AdaptHealth Corp
UMushroom community rating:
About company
AdaptHealth Corp is a national leader in healthcare-at-home solutions, serving approximately 4.1 million patients annually in 47 states through a network of approximately 680 locations. The company's focus on compliance is evident through its industry-leading compliance program that spans the entire enterprise, supported by the Board of Directors and Executive Leadership Team. With a team of over 1,000 clinicians, AdaptHealth provides leading therapies and leverages scale and technology to deliver crucial therapies on time and at lower cost. The company's innovation in technology, such as proprietary cloud-based mobile delivery software, has established AdaptHealth as an industry leader in tech-enabled patient engagement. Additionally, AdaptHealth manages a fleet of vehicles for delivering products to customers and operates retail storefronts, warehouses, and office spaces.
Summarized from source with an LLMView SourceSector: FinanceLatest Results (14.01.2025):
Revenue Growth
AdaptHealth Corp. reported net revenue of $805.9 million for the third quarter of 2024, marking a slight increase of 0.2% compared to $804.0 million in the same quarter of the previous year.
Net Income Improvement
For the third quarter of 2024, AdaptHealth Corp. achieved a net income of $22.9 million, a significant turnaround from a net loss of $454.1 million in the third quarter of 2023.
Adjusted EBITDA Increase
AdaptHealth Corp.'s adjusted EBITDA for the third quarter of 2024 was $164.3 million, reflecting a 1.9% increase from $161.2 million in the same period of the previous year.
Cash Flow Enhancement
Year-to-date 2024, AdaptHealth Corp. reported cash flow from operations of $391.4 million, up from $325.4 million during the comparable period in 2023. Free cash flow also increased to $162.7 million from $76.6 million year-to-date 2023.
Updated Financial Outlook
AdaptHealth Corp. revised its financial guidance for fiscal year 2024, projecting net revenue between $3.220 billion and $3.260 billion, adjusted EBITDA between $655 million and $675 million, and free cash flow between $175 million and $195 million.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1192 M
Market cap (USD)
1,233,041
Daily traded volume (Shares)
9.53 / 9.22
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
